Page 3 - Mannin Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Q BioMed Updates Shareholders Technology partner, Mannin Research, receives new R&D funding for COVID project and Several Milestones Expected in 2021 News provided by Share this article Share this article NEW YORK, April 27, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, updates shareholders. In March 2021,it was announced that our technology partner, Mannin Research Inc. (Mannin), is receiving up to CAD$1.7 million in research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to supp...

MAN-19 is designed to treat Acute Respiratory Distress Syndrome in coronavirus patients but is virus agnostic, making it a potential government...

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Weekend Unlimited Inc (CSE:POT) (OTCQB:WKULF), a North American recreational cannabis and CBD wellness company, announced that it intends to change its name to Potent Ventures Inc. The Vancouver-based group also said that it plans to subdivide its common shares based on four new shares for every one existing common share. The company said that as part of the share split, registered shareholders of the company will receive four shares for eac...

Vector Institute. It leverages past work of partners to address needs of infectious disease research with guidance from domain experts. "We are very proud to contribute to such an important effort in Canada, as it will have an impact not only on Canadian's healthcare but on COVID-19 patients around the world, as we learn more about the disease and ways we can treat patients with it," said George N. Nikopoulos, President and CEO of Mannin Research Inc. For more information, visit About Mannin Research Inc. Mannin Research is a research-stage biotechnology company focused on the discovery, de...